Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 18, Pages 4626
Publisher
MDPI AG
Online
2021-09-16
DOI
10.3390/cancers13184626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
- (2021) Willem J. Koemans et al. Gastric Cancer
- Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial
- (2021) Willem J. Koemans et al. JOURNAL OF SURGICAL ONCOLOGY
- Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results
- (2020) R. T. van der Kaaij et al. BRITISH JOURNAL OF SURGERY
- The metastatic pattern of intestinal and diffuse type gastric carcinoma – A Dutch national cohort study
- (2020) W.J. Koemans et al. Cancer Epidemiology
- Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
- (2020) W.O. de Steur et al. ANNALS OF ONCOLOGY
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
- (2019) W. J. Koemans et al. BMC CANCER
- Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study
- (2019) I. Mokadem et al. Gastric Cancer
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Gastric Cancer Peritoneal Carcinomatosis Risk Score
- (2019) Liang Ji et al. ANNALS OF SURGICAL ONCOLOGY
- Peritoneal metastasis in gastric cancer: results from the German database
- (2019) Beate Rau et al. Gastric Cancer
- Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
- (2019) Charlotte E L Klaver et al. Lancet Gastroenterology & Hepatology
- Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
- (2019) H. J. F. Brenkman et al. Journal of Clinical Medicine
- Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma
- (2018) Jun H. Lee et al. ANNALS OF SURGERY
- Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial
- (2018) Y.H.M. Claassen et al. EJSO
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
- (2018) Annemieke Cats et al. LANCET ONCOLOGY
- CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
- (2018) Astrid E. Slagter et al. BMC CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
- (2018) Y. H. M. Claassen et al. Gastric Cancer
- Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
- (2018) Cristina Rihuete Caro et al. EJSO
- Microscopic peritoneal carcinomatosis in gastric cancer: Prevalence, prognosis and predictive factors
- (2017) Enrico Pasqual et al. Oncology Letters
- Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration
- (2016) Jee Suk Chang et al. JOURNAL OF SURGICAL ONCOLOGY
- Metastatic spread in patients with gastric cancer
- (2016) Matias Riihimäki et al. Oncotarget
- Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients
- (2015) Florian Seyfried et al. BMC CANCER
- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
- (2015) Trevor Leong et al. BMC CANCER
- GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study
- (2014) Olivier Glehen et al. BMC CANCER
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
- (2014) Gaya Spolverato et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin
- (2013) Irene Thomassen et al. ACTA ONCOLOGICA
- Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: Results of a multicentre retrospective study
- (2013) C. Honoré et al. EJSO
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
- (2011) Johan L Dikken et al. BMC CANCER
- Evaluation of the 7th UICC TNM Staging System of Gastric Cancer
- (2011) Sung Joon Kwon Journal of Gastric Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started